home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Mouse Brain Tumour Model Highlights Causative Role for Gene Duo

 
  October, 30 2008 3:22
your information resource in human molecular genetics
 
     
Two genes have been implicated in the development of a lethal brain tumour, highlighting potential targets for therapeutic development.

Glioblastomas are the most common and aggressive type of primary brain tumour. In Nature, Ronald DePinho and colleagues report that deleting two genes, p53 and Pten, from mouse brains causes the animals to develop glioblastoma-like tumours. Furthermore, they show that both genes are frequently inactivated in human glioblastomas.

It's thought that these tumours develop from rogue neural stem cells, so the team also looked at cultured mouse brain stem cells. Inactivating p53 and Pten kept the cells in an undifferentiated, stem-cell-like state, and they expressed high levels of the cancer-associated protein Myc. Together the studies implicate the combined actions of p53 and Pten in glioblastoma and highlight Myc as a possible target for future therapies.

CONTACT

Ronald DePinho (Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA)
E-mail: ron_depinho@dfci.harvard.edu    

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.